Who
Nancy R. Phelan
Director
Company insider
Files Form 4 as: Director, Achieve Life Sciences; CEO and Secretary, Adhera Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 4 Apr 2019
- Last trade
- 27 Jul 2026
- Last filed
- 29 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,700 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,700 at $0.00 | filing |
| 6 Jun 2025filed 10 Jun 2025 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —31,500 at $0.00 | filing |
| 13 Jan 2025filed 14 Jan 2025 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —47,250 at $0.00 | filing |
| 4 Apr 2019filed 4 Apr 2019 | Adhera Therapeuticsoption or derivative | SEC FORM 4 Code A | —1,500,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.